ADX10059, an experimental drug can block movement disorder dystonia symptoms induced by levodopa in Parkinson's disease patients, Addex Pharma said in a press statement.

At least 3 of Glenmark lead molecules failed or got suspended in mid-stage trials in the recent months

New technology has been tested successfully on colon and prostate cancer

SUVN-502 patent is valid till June 2023 in all the nine countries

Piramal Life has a drug discovery pipeline comprising 14 molecules

REG1, a new drug than can make the commonly used anti-blood clotting drugs safer by reversing its harmful side-effects has been developed by Regado Biosciences, Inc.

A new safer drug toxicity test to minimize the drug failure rates in clinical trials for cancer treatmants has been developed.

Piramal Life presents safety data of new antibacterial drug to treat multi-drug resistant infections

Suven Life Sciences, based in Hyderabad, South India, entered into drug discovery collaboration with Eli Lilly and Company, in 2008, USA to jointly discover and develop candidates for the treatment of CNS disorders. Suven achieved the first milestone with the identification and selection of a first lead ...

Jubilant has signed similar drug discovery services deals with AstraZeneca, Eli Lilly, Amgen, Orion and Bio Leap over the last 18 months.